Imdelltra Gets Accelerated Approval for Extensive-Stage SCLC

The FDA has granted accelerated approval to Imdelltra (tarlatamab-dlle) for extensive stage small cell lung cancer.

Related Keywords

Davidp Carbone , , James Thoracic Oncology Center , Ohio State University Medical Center , Drug Administration , Ohio State University Medical , Boxed Warning ,